Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Vanda Pharmaceuticals, Inc.
February 26 2019 - 3:47PM
Business Wire
Federman & Sherwood announces that on February 25, 2019, a
class action lawsuit was filed in the United States District Court
for the Eastern District of New York against Vanda Pharmaceuticals,
Inc. (NASDAQ: VNDA). The complaint alleges violations of federal
securities laws, Sections 10(b) and 20(a) of the Securities
Exchange Act of 1934 and Rule 10b-5, including allegations of
issuing a series of material or false misrepresentations to the
market which had the effect of artificially inflating the market
price during the Class Period, which is November 4, 2015 through
February 11, 2019.
Plaintiff seeks to recover damages on behalf of all Vanda
Pharmaceuticals, Inc. shareholders who purchased common stock
during the Class Period and are therefore a member of the Class as
described above. You may move the Court no later than Friday, April
26, 2019 to serve as a lead plaintiff for the entire Class.
However, in order to do so, you must meet certain legal
requirements pursuant to the Private Securities Litigation Reform
Act of 1995.
If you wish to discuss this action, obtain further information
and participate in this or any other securities litigation, or
should you have any questions or concerns regarding this notice or
preservation of your rights, please contact:
Robin HesterFEDERMAN & SHERWOOD10205 North Pennsylvania
AvenueOklahoma City, OK 73120Email to: rkh@federmanlaw.comOr, visit
the firm’s website at www.federmanlaw.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190226006137/en/
Robin HesterFEDERMAN &
SHERWOODrkh@federmanlaw.comwww.federmanlaw.com
Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart
From Apr 2023 to Apr 2024